{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:07:43Z","timestamp":1788829663984,"version":"build-2803163510"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.crad.2026.107399","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T16:24:28Z","timestamp":1779899068000},"page":"107399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nuclear medicine techniques in gynaecological malignancy: a review of best practice"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6967-4535","authenticated-orcid":false,"given":"S.","family":"Canham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.R.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7257-7488","authenticated-orcid":false,"given":"M.","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9776-8766","authenticated-orcid":false,"given":"T.D.","family":"Barwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crad.2026.107399_bib3","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1007\/s00259-020-05112-2","article-title":"EANM\/SNMMI practice guideline for [18 F]FDG PET\/CT external beam radiotherapy treatment planning in uterine cervical cancer v1.0","volume":"48","author":"Adam","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.crad.2026.107399_bib4","article-title":"Global determinants of cervical cancer outcomes: a health systems analysis","volume":"5","author":"Go","year":"2026","journal-title":"BMJ Oncol"},{"key":"10.1016\/j.crad.2026.107399_bib6","unstructured":"Cervical cancer statistics | Cancer Research UK n.d. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/cervical-cancer (accessed February 24, 2026)."},{"key":"10.1016\/j.crad.2026.107399_bib7","series-title":"NHS cervical screening programme audit of invasive cervical cancer: national report","year":"2023"},{"key":"10.1016\/j.crad.2026.107399_bib8","series-title":"Cervical cancer survival","year":"2023"},{"issue":"10462","key":"10.1016\/j.crad.2026.107399_bib9","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(24)01438-7","article-title":"Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial","volume":"404","author":"McCormack","year":"2024","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.crad.2026.107399_bib10","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1148\/rg.2020200013","article-title":"2018 figo staging classification for cervical cancer: added benefits of imaging","volume":"40","author":"Salib","year":"2020","journal-title":"Radiographics"},{"issue":"1","key":"10.1016\/j.crad.2026.107399_bib11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ijgo.12749","article-title":"Revised FIGO staging for carcinoma of the cervix uteri","volume":"145","author":"Bhatla","year":"2019","journal-title":"Int J Gynecol Obstetr"},{"issue":"10","key":"10.1016\/j.crad.2026.107399_bib12","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.1007\/s00330-020-06909-3","article-title":"Diagnostic performance of conventional and advanced imaging modalities for assessing newly diagnosed cervical cancer: systematic review and meta-analysis","volume":"30","author":"Woo","year":"2020","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.crad.2026.107399_bib13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/ijgc-2023-004429","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with cervical cancer - update 2023","volume":"33","author":"Cibula","year":"2023","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"10.1016\/j.crad.2026.107399_bib14","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00259-014-2732-8","article-title":"The EANM clinical and technical guidelines for lymphoscintigraphy and sentinel node localization in gynaecological cancers","volume":"41","author":"Giammarile","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"13","key":"10.1016\/j.crad.2026.107399_bib15","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1200\/JCO.2010.32.0432","article-title":"Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study","volume":"29","author":"L\u00e9curu","year":"2011","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.crad.2026.107399_bib16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ejso.2008.09.004","article-title":"Sentinel lymph node sampling in gynaecological cancers: techniques and clinical applications","volume":"35","author":"El-Ghobashy","year":"2009","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.crad.2026.107399_bib17","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2967\/jnumed.114.152439","article-title":"99mTc SPECT\/CT versus planar lymphoscintigraphy for preoperative sentinel lymph node detection in cervical cancer: a systematic review and metaanalysis","volume":"56","author":"Hoogendam","year":"2015","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.crad.2026.107399_bib18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/j.semnuclmed.2019.06.007","article-title":"FDG-PET imaging in cervical cancer","volume":"49","author":"Gandy","year":"2019","journal-title":"Semin Nucl Med"},{"issue":"3","key":"10.1016\/j.crad.2026.107399_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000456006","article-title":"A comprehensive comparison of CT, MRI, positron emission tomography or positron emission tomography\/CT, and diffusion weighted imaging-MRI for detecting the lymph nodes metastases in patients with cervical cancer: a meta-analysis based on 67 studies","volume":"82","author":"Liu","year":"2017","journal-title":"Gynecol Obstet Invest"},{"issue":"23","key":"10.1016\/j.crad.2026.107399_bib20","doi-asserted-by":"crossref","first-page":"6457","DOI":"10.1158\/1078-0432.CCR-21-1834","article-title":"Diagnostic accuracy of FEC-PET\/CT, FDG-PET\/CT, and diffusion-weighted MRI in detection of nodal metastases in surgically treated endometrial and cervical carcinoma","volume":"27","author":"Rockall","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.crad.2026.107399_bib21","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ygyno.2020.08.021","article-title":"[18F]FDG-PET or PET\/CT in the evaluation of pelvic and para-aortic lymph nodes in patients with locally advanced cervical cancer: a systematic review of the literature","volume":"159","author":"Adam","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.crad.2026.107399_bib22","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ejogrb.2022.03.042","article-title":"Interest of para-aortic lymphadenectomy for locally advanced cervical cancer in the era of PET scanning","volume":"272","author":"Khebbeb","year":"2022","journal-title":"Eur J Obstetr Gynecol Reproduct Biol"},{"issue":"9","key":"10.1016\/j.crad.2026.107399_bib23","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/cncr.25739","article-title":"Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer 1","volume":"117","author":"Ramirez","year":"2011","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.crad.2026.107399_bib24","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/1471-0528.14492","article-title":"Survival effect of laparoscopic para-aortic staging in locally advanced cervical cancer: a retrospective cohort analysis","volume":"124","author":"Pomel","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.crad.2026.107399_bib25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejogrb.2020.08.020","article-title":"British Gynaecological Cancer Society (BGCS) cervical cancer guidelines: recommendations for practice","volume":"256","author":"Reed","year":"2021","journal-title":"Eur J Obstetr Gynecol Reproduct Biol"},{"issue":"12","key":"10.1016\/j.crad.2026.107399_bib26","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.21873\/anticanres.17885","article-title":"Comparative analysis of FDG-PET versus CT\/MRI in staging and management of advanced-stage cervical cancer","volume":"45","author":"Nayab","year":"2025","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.crad.2026.107399_bib27","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/ijgc-2018-000108","article-title":"Detection of distant metastatic disease by positron emission tomography with 18 F-fluorodeoxyglucose (FDG-PET) at initial staging of cervical carcinoma","volume":"29","author":"Lin","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"10.1016\/j.crad.2026.107399_bib28","first-page":"1615","article-title":"Original article patterns of metastases in cervical cancer: a population-based study","volume":"13","author":"Zhou","year":"2020","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"10.1016\/j.crad.2026.107399_bib29","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1148\/radiol.2017170963","article-title":"Identification of distant metastatic disease in uterine cervical and endometrial cancers with FDG PET\/CT: analysis from the ACRIN 6671\/GOG 0233 multicenter trial","volume":"287","author":"Gee","year":"2018","journal-title":"Radiology"},{"issue":"10","key":"10.1016\/j.crad.2026.107399_bib30","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s12149-018-1289-1","article-title":"Prognostic value of volume-based metabolic parameters of 18 F-FDG PET\/CT in ovarian cancer: a systematic review and meta-analysis","volume":"32","author":"Han","year":"2018","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.crad.2026.107399_bib31","series-title":"Evidence-based indications for the use of PET-CT in the United Kingdom 2022","article-title":"British Nuclear Medicine Society, administration of radioactive substances advisory committee","year":"2022"},{"key":"10.1016\/j.crad.2026.107399_bib32","series-title":"NCCN clinical practice guidelines in oncology: cervical cancer","year":"2026"},{"issue":"4","key":"10.1016\/j.crad.2026.107399_bib33","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00259-016-3537-8","article-title":"Efficacy of qualitative response assessment interpretation criteria at 18F-FDG PET-CT for predicting outcome in locally advanced cervical carcinoma treated with chemoradiotherapy","volume":"44","author":"Scarsbrook","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"10.1016\/j.crad.2026.107399_bib34","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1136\/ijgc-2023-004703","article-title":"Prognostic significance of delayed complete metabolic response on PET\/CT after primary chemoradiation treatment of cervical cancer","volume":"33","author":"Michaan","year":"2023","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.crad.2026.107399_bib35","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ijrobp.2018.01.092","article-title":"Use of functional magnetic resonance imaging in cervical cancer patients with incomplete response on positron emission tomography\/computed tomography after image-based high-dose-rate brachytherapy","volume":"102","author":"Kalash","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.crad.2026.107399_bib36","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/ijgc-2018-000091","article-title":"Utility of 18F-FDG-PET\/CT imaging in patients with recurrent gynecological malignancies prior to pelvic exenteration","volume":"29","author":"Kim","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.crad.2026.107399_bib37","unstructured":"Uterine cancer statistics | Cancer Research UK n.d. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/uterine-cancer (accessed February 24, 2026)."},{"issue":"2","key":"10.1016\/j.crad.2026.107399_bib38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynecol Obstetr"},{"issue":"5","key":"10.1016\/j.crad.2026.107399_bib39","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s40336-020-00385-x","article-title":"The role of 18F-FDG PET\/CT in endometrial adenocarcinoma: a review of the literature and recent advances","volume":"8","author":"Garau","year":"2020","journal-title":"Clin Transl Imaging"},{"issue":"8","key":"10.1016\/j.crad.2026.107399_bib40","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1016\/S1470-2045(25)00167-6","article-title":"ESGO\u2013ESTRO\u2013ESP guidelines for the management of patients with endometrial carcinoma: update 2025","volume":"26","author":"Concin","year":"2025","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.crad.2026.107399_bib41","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1007\/s00330-019-06622-w","article-title":"Preoperative 18F-FDG PET\/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer","volume":"30","author":"Fasmer","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.crad.2026.107399_bib42","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.crad.2026.107399_bib43","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.annonc.2022.05.009","article-title":"Endometrial cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"33","author":"Oaknin","year":"2022","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.crad.2026.107399_bib44","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1136\/ijgc-2021-002703","article-title":"Endometrial cancer lymphadenectomy trial (ECLAT) (pelvic and para-aortic lymphadenectomy in patients with stage i or II endometrial cancer with high risk of recurrence; AGO-OP.6)","volume":"31","author":"Emons","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.crad.2026.107399_bib45","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00404-019-05207-8","article-title":"Diagnostic accuracy of preoperative 18F-FDG PET or PET\/CT in detecting pelvic and para-aortic lymph node metastasis in patients with endometrial cancer: a systematic review and meta-analysis","volume":"300","author":"Hu","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.crad.2026.107399_bib46","article-title":"Diagnostic performance of quantitative measures from [18F]FDG PET\/CT, [18F]FEC PET\/CT, and DW-MRI in the detection of lymph node metastases in endometrial and cervical cancer: data from the MAPPING study","author":"King","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2026.107399_bib47","series-title":"NCCN clinical practice guidelines in oncology: uterine cancer","year":"2026"},{"issue":"11","key":"10.1016\/j.crad.2026.107399_bib48","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.21037\/tcr-2025-1635","article-title":"Prognostic characteristics and recurrence patterns of grade 1 endometrial carcinoma: a large retrospective analysis of a tertiary center","volume":"14","author":"Sadeghi","year":"2025","journal-title":"Transl Cancer Res"},{"issue":"11","key":"10.1016\/j.crad.2026.107399_bib49","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.clon.2024.06.001","article-title":"Endometrial cancer: analysing patterns of recurrence and real-life outcome data using the 2020 ESGO-ESTRO-ESP risk stratification system","volume":"36","author":"Karkia","year":"2024","journal-title":"Clin Oncol"},{"issue":"6","key":"10.1016\/j.crad.2026.107399_bib50","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2967\/jnumed.115.170597","article-title":"High diagnostic value of 18F-FDG PET\/CT in endometrial cancer: systematic review and meta-analysis of the literature","volume":"57","author":"Bollineni","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2026.107399_bib51","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejogrb.2024.06.025","article-title":"British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: recommendations for practice update 2024","volume":"300","author":"Moss","year":"2024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"10.1016\/j.crad.2026.107399_bib52","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12149-010-0449-8","article-title":"Present and future of FDG-PET\/CT in ovarian cancer","volume":"25","author":"Kitajima","year":"2011","journal-title":"Ann Nucl Med"},{"issue":"7","key":"10.1016\/j.crad.2026.107399_bib53","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/ijgc-2021-002565","article-title":"ESGO\/ISUOG\/IOTA\/ESGE consensus statement on pre-operative diagnosis of ovarian tumors","volume":"31","author":"Timmerman","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.crad.2026.107399_bib54","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1148\/rg.2017160059","article-title":"FDG PET\/CT pitfalls in gynecologic and genitourinary oncologic imaging","volume":"37","author":"Lakhani","year":"2017","journal-title":"Radiographics"},{"issue":"6","key":"10.1016\/j.crad.2026.107399_bib55","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1007\/s00261-024-04195-x","article-title":"Diagnostic accuracy of contrast-enhanced CT versus PET\/CT for advanced ovarian cancer staging: a comparative systematic review and meta-analysis","volume":"49","author":"Wilson","year":"2024","journal-title":"Abdom Radiol (NY)"},{"issue":"7","key":"10.1016\/j.crad.2026.107399_bib56","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/MNM.0000000000001977","article-title":"The role of 68Ga-FAPI PET\/CT imaging in gynecological cancers: an integrative review","volume":"46","author":"Usmani","year":"2025","journal-title":"Nucl Med Commun"},{"issue":"7","key":"10.1016\/j.crad.2026.107399_bib57","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1007\/s00330-024-11300-7","article-title":"Ovarian cancer staging and follow-up: updated guidelines from the European Society of Urogenital Radiology female pelvic imaging working group","volume":"35","author":"Rizzo","year":"2025","journal-title":"Eur Radiol"},{"issue":"10","key":"10.1016\/j.crad.2026.107399_bib58","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1007\/s00259-021-05450-9","volume":"48","author":"Delgado Bolton","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2026.107399_bib59","series-title":"NCCN clinical practice guidelines in oncology: ovarian cancer. Including fallopian tube cancer and primary peritoneal cancer","year":"2026"},{"issue":"1","key":"10.1016\/j.crad.2026.107399_bib60","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3390\/curroncol30010083","article-title":"Current update on PET\/MRI in gynecological malignancies\u2014A review of the literature","volume":"30","author":"Virarkar","year":"2023","journal-title":"Current Oncol"},{"issue":"8","key":"10.1016\/j.crad.2026.107399_bib61","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.ejso.2021.03.239","article-title":"Assessment of peritoneal metastases with DW-MRI, CT, and FDG PET\/CT before cytoreductive surgery for advanced stage epithelial ovarian cancer","volume":"47","author":"Mikkelsen","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"10.1016\/j.crad.2026.107399_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16081467","article-title":"Imaging of peritoneal metastases in ovarian cancer using MDCT, MRI, and FDG PET\/CT: a systematic review and meta-analysis","volume":"16","author":"Tsili","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.crad.2026.107399_bib63","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.annonc.2023.11.015","article-title":"ESGO\u2013ESMO\u2013ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease","volume":"35","author":"Ledermann","year":"2024","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.crad.2026.107399_bib64","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/RLU.0000000000004839","article-title":"Impact of 18F-FDG PET on the management in patients with recurrent gynecologic cancer: a meta-analysis","volume":"48","author":"Pak","year":"2023","journal-title":"Clin Nucl Med"},{"issue":"Suppl 1","key":"10.1016\/j.crad.2026.107399_bib65","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.108.057257","article-title":"The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries","volume":"50","author":"Schwarz","year":"2009","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.crad.2026.107399_bib66","first-page":"233","article-title":"PET\/TC con 18F-FDG como predictor de la biolog\u00eda tumoral y del pron\u00f3stico en el c\u00e1ncer epitelial ov\u00e1rico","volume":"36","author":"Gonz\u00e1lez Garc\u00eda","year":"2017","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"issue":"4","key":"10.1016\/j.crad.2026.107399_bib67","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3390\/cancers17040698","article-title":"Prognostic value of pretreatment 18F-FDG-PET\/CT metabolic parameters in advanced high-grade serous ovarian cancer","volume":"17","author":"Travaglio Morales","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.crad.2026.107399_bib68","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1007\/s00330-015-3729-9","article-title":"Volume-based quantitative FDG PET\/CT metrics and their association with optimal debulking and progression-free survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery","volume":"25","author":"Vargas","year":"2015","journal-title":"Eur Radiol"},{"key":"10.1016\/j.crad.2026.107399_bib69","unstructured":"Vaginal cancer statistics | Cancer Research UK n.d. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/vaginal-cancer (accessed February 24, 2026)."},{"key":"10.1016\/j.crad.2026.107399_bib70","unstructured":"Vulval cancer statistics | Cancer Research UK n.d. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/vulval-cancer (accessed February 24, 2026)."},{"issue":"12","key":"10.1016\/j.crad.2026.107399_bib71","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1007\/s00261-021-03209-2","article-title":"Gynecologic tumor board: a radiologist\u2019s guide to vulvar and vaginal malignancies","volume":"46","author":"Chow","year":"2021","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.crad.2026.107399_bib72","series-title":"Vaginal cancer pocket guidelines","year":"2023"},{"key":"10.1016\/j.crad.2026.107399_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109662","article-title":"ESTRO\/ESGO\/SIOPe guidelines for the management of patients with vaginal cancer","volume":"186","author":"Nout","year":"2023","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.crad.2026.107399_bib74","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ygyno.2016.01.011","article-title":"The impact of FDG-PET\/CT in the management of patients with vulvar and vaginal cancer","volume":"140","author":"Robertson","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.crad.2026.107399_bib75","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ijrobp.2004.12.011","article-title":"FDG-PET evaluation of vaginal carcinoma","volume":"62","author":"Lamoreaux","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.crad.2026.107399_bib76","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/ijgc-2023-004486","article-title":"European Society of Gynaecological Oncology Guidelines for the management of patients with vulvar cancer - update 2023","volume":"33","author":"Oonk","year":"2023","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.crad.2026.107399_bib77","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.2007.14.0566","article-title":"Sentinel node dissection is safe in the treatment of early-stage vulvar cancer","volume":"26","author":"Van Der Zee","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.crad.2026.107399_bib78","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ygyno.2015.02.014","article-title":"Sentinel lymph node biopsy in vulvar cancer: systematic review, meta-analysis and guideline recommendations","volume":"137","author":"Covens","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.crad.2026.107399_bib79","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00259-019-04650-8","article-title":"Lymphoscintigraphy and sentinel lymph node biopsy in vulvar carcinoma: update from a European expert panel","volume":"47","author":"Collarino","year":"2020","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.crad.2026.107399_bib80","series-title":"NCCN clinical practice guidelines in oncology: vulvar cancer","year":"2026"},{"issue":"10","key":"10.1016\/j.crad.2026.107399_bib81","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1007\/s00259-021-05257-8","article-title":"Diagnostic performance of preoperative [18F]FDG-PET\/CT for lymph node staging in vulvar cancer: a large single-centre study","volume":"48","author":"Rufini","year":"2021","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"2","key":"10.1016\/j.crad.2026.107399_bib82","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/RLU.0000000000003411","article-title":"18F-FDG PET and 18F-FDG PET\/CT in vulvar cancer: a systematic review and meta-analysis","volume":"46","author":"Triumbari","year":"2021","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2026.107399_bib83","series-title":"NCCN clinical practice guidelines in oncology: vaginal cancer","year":"2026"},{"issue":"1","key":"10.1016\/j.crad.2026.107399_bib84","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11604-021-01173-x","article-title":"Clinical and prognostic 18F-FDG PET\/CT role in recurrent vulvar cancer: a multicentric experience","volume":"40","author":"Albano","year":"2021","journal-title":"Jpn J Radiol"},{"issue":"11","key":"10.1016\/j.crad.2026.107399_bib85","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1007\/s00259-025-07277-0","article-title":"Head-to-head comparison of fibroblast activation protein inhibitors (FAPI) radiopharmaceuticals and [18F]FDG in gynaecological malignancies: systematic literature review and meta-analysis","volume":"52","author":"Florit","year":"2025","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"1","key":"10.1016\/j.crad.2026.107399_bib86","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3892\/ol.2015.3151","article-title":"Expression levels of seprase\/FAP\u03b1 and DPPIV\/CD26 in epithelial ovarian carcinoma","volume":"10","author":"Zhang","year":"2015","journal-title":"Oncol Lett"},{"key":"10.1016\/j.crad.2026.107399_bib87","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1007\/s00259-021-05378-0","article-title":"68Ga-FAPI-PET\/CT in patients with various gynecological malignancies","volume":"48","author":"Dendl","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2026.107399_bib88","article-title":"Advances in the application of radionuclide-labeled HER2 affibody for the diagnosis and treatment of ovarian cancer","volume":"12","author":"Hu","year":"2022","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.crad.2026.107399_bib89","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.21037\/tcr-2025-618","article-title":"Artificial intelligence radiomics in the diagnosis, treatment, and prognosis of gynecological cancer: a literature review","volume":"14","author":"Bai","year":"2025","journal-title":"Transl Cancer Res"},{"issue":"9","key":"10.1016\/j.crad.2026.107399_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15092407","article-title":"Long axial field-of-view PET\/CT could answer unmet needs in gynecological cancers","volume":"15","author":"Triumbari","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.crad.2026.107399_bib91","series-title":"Vulvar cancer guidelines","year":"2016"},{"key":"10.1016\/j.crad.2026.107399_bib92","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejogrb.2023.11.013","article-title":"British Gynaecological Cancer Society (BGCS) vulval cancer guidelines: an update on recommendations for practice 2023","volume":"292","author":"Morrison","year":"2024","journal-title":"Eur J Obstetr Gynecol Reproduct Biol"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926026001753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926026001753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:25:51Z","timestamp":1788827151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926026001753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":89,"alternative-id":["S0009926026001753"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2026.107399","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nuclear medicine techniques in gynaecological malignancy: a review of best practice","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2026.107399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier Ltd on behalf of The Royal College of Radiologists. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107399"}}